Intrinsic Value of S&P & Nasdaq Contact Us

Tiziana Life Sciences Ltd TLSA NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • GB • USD

SharesGrow Score
43/100
1/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — TLSA

Tiziana Life Sciences Ltd (TLSA) has a market capitalization of $79.04M and trades at $1.33. The 52-week range is 0.73-2.6.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6, Earnings Per Share (EPS) of $-0.22.

The stock has a beta of 0.37, operates in the Healthcare sector.

Trading Data
Current Price$1.33
52-Week Range0.73-2.6
Volume141.01K
Avg Volume (30D)197.59K
Market Cap$79.04M
Beta (1Y)0.37
Company
IPO Date2018-11-20
Employees9
CEOIvor R. Elrifi
CountryGB
ExchangeNASDAQ Global Market
CurrencyUSD
ISINBMG889121031
CUSIP88875G101
Income (Latest Year)
EBITDA$-16.62M
Operating Income$-15.79M
Net Income$-11.86M
EPS$-0.22
EPS Diluted$-0.22
Shares Outstanding$53.34M
Balance Sheet (Latest Year)
Total Assets$11.28M
Current Assets$7.51M
Cash & ST Investments$3.72M
Total Liabilities$7.35M
Total Debt$106K
Net Debt$-3.62M
Total Equity$3.94M
Debt / Equity0.03
Valuation Ratios
P/E Ratio-6
P/B Ratio20.08
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message